Histone Deacetylase Inhibitor for Neurodegenerative Diseases: A Possible Medicinal Strategy by Prevention of ER Stress-Mediated Apoptosis and Neurite Elongation

Clinic Pharmacol Biopharmaceut A Possible Pharmacological Strategy for Nerve Diseases ISSN: 2167-065X CPB an open access journal Koji Shimoke1,2*, Takuma Tomioka2, Kouta Okamoto2, Daichi Fujiki2, Shinichi Uesato1,2, Hitoshi Nakayama3 and Toshihiko Ikeuchi1,2 1Department of Life Science and Biotechnology, Faculty of Chemistry, Materials and Bioengineering, Kansai University, Japan 2Graduate School of Science and Engineering, Kansai University, Japan 3Department of Pharmacology, Nara Medical University, School of Medicine, Japan

[1]  G. Gobbi,et al.  Characterization of serotonin neurotransmission in knockout mice: implications for major depression , 2012, Reviews in the neurosciences.

[2]  P. Szot.  Common factors among Alzheimer’s disease, Parkinson’s disease, and epilepsy: Possible role of the noradrenergic nervous system , 2012, Epilepsia.

[3]  A. Letai,et al.  BH3‐only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α , 2012, The EMBO journal.

[4]  K. Shimoke,et al.  New Orally Bioavailable 2-aminobenzamide-type Histone Deacetyase Inhibitor Promotes Neurite Outgrowth via histone H3 Modification in PC12 cells: a Possible Therapeutic Candidate for Neuronal Diseases , 2011 .

[5]  K. Shimoke,et al.  Appearance of Nuclear-sorted Caspase-12 Fragments in Cerebral Cortical and Hippocampal Neurons in Rats Damaged by Autologous Blood Clot Embolic Brain Infarctions , 2011, Cellular and Molecular Neurobiology.

[6]  J. Kwok,et al.  Role of epigenetics in Alzheimer's and Parkinson's disease. , 2010, Epigenomics.

[7]  K. Shimoke,et al.  Dibutyryl-cAMP up-regulates nur77 expression via histone modification during neurite outgrowth in PC12 cells. , 2010, Journal of biochemistry.

[8]  R. Orpwood.  Perceptual qualia and local network behavior in the cerebral cortex. , 2010, Journal of integrative neuroscience.

[9]  S. Uesato,et al.  New orally bioavailable 2-aminobenzamide-type histone deacetylase inhibitor possessing a (2-hydroxyethyl)(4-(thiophen-2-yl)benzyl)amino group. , 2010, Bioorganic & medicinal chemistry.

[10]  K. Shin‐ya,et al.  Nerve growth factor attenuates 2-deoxy-d-glucose-triggered endoplasmic reticulum stress-mediated apoptosis via enhanced expression of GRP78 , 2010, Neuroscience Research.

[11]  H. Ploegh,et al.  Mechanisms, biology and inhibitors of deubiquitinating enzymes. , 2007, Nature chemical biology.

[12]  J. Cha,et al.  Mechanisms of Disease: histone modifications in Huntington's disease , 2006, Nature Clinical Practice Neurology.

[13]  K. Shimoke,et al.  NGF-induced phosphatidylinositol 3-kinase signaling pathway prevents thapsigargin-triggered ER stress-mediated apoptosis in PC12 cells , 2005, Neuroscience Letters.

[14]  K. Shimoke,et al.  Prevention of endoplasmic reticulum stress-induced cell death by brain-derived neurotrophic factor in cultured cerebral cortical neurons , 2004, Brain Research.

[15]  D. Bredesen,et al.  Coupling endoplasmic reticulum stress to the cell death program , 2004, Cell Death and Differentiation.

[16]  K. Shimoke,et al.  Nerve growth factor attenuates endoplasmic reticulum stress-mediated apoptosis via suppression of caspase-12 activity. , 2004, Journal of biochemistry.

[17]  Tullio Pozzan,et al.  BAX and BAK Regulation of Endoplasmic Reticulum Ca2+: A Control Point for Apoptosis , 2003, Science.

[18]  S. Cory,et al.  Apoptosomes: engines for caspase activation. , 2002, Current opinion in cell biology.

[19]  R. Kaufman.  Orchestrating the unfolded protein response in health and disease. , 2002, The Journal of clinical investigation.

[20]  David R Kaplan,et al.  Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.

[21]  S. Minoshima,et al.  Progress in the clinical and molecular genetics of familial parkinsonism , 2000, Neurogenetics.

[22]  Junying Yuan,et al.  Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β , 2000, Nature.

[23]  Y. Itoyama,et al.  Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response , 1999, Nature Cell Biology.

[24]  H. Hatanaka,et al.  Brain-derived Neurotrophic Factor Induces Rapid and Transient Release of Glutamate through the Non-exocytotic Pathway from Cortical Neurons* , 1998, The Journal of Biological Chemistry.

[25]  John Calvin Reed,et al.  Mechanisms of Bcl-2 protein function. , 1998, Histology and histopathology.

[26]  S. Nagata,et al.  A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.

[27]  K. Shimoke,et al.  Involvement of phosphatidylinositol-3 kinase in prevention of low K(+)-induced apoptosis of cerebellar granule neurons. , 1997, Brain research. Developmental brain research.

[28]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[29]  D. Rubinsztein,et al.  Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number. , 1993, Human molecular genetics.

[30]  J. Hardy,et al.  Amyloid precursor protein gene mutation in early-onset Alzheimer's disease , 1991, The Lancet.

[31]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[32]  P Strata,et al.  Involvement of cerebellum in emotional behavior. , 2011, Physiological research.

[33]  K. Shimoke,et al.  Analysis of the role of nerve growth factor in promoting cell survival during endoplasmic reticulum stress in PC12 cells. , 2011, Methods in enzymology.

[34]  O. Arancio,et al.  Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. , 2009, Journal of Alzheimer's disease : JAD.

[35]  G. Vega,et al.  Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. , 1999, Biological psychiatry.

[36]  R. Oppenheim.  Cell death during development of the nervous system. , 1991, Annual review of neuroscience.

[37]  Patrik Vuilleumier,et al.  Emotional processing and its impact on unilateral neglect and extinction , 2012, Neuropsychologia.